{"id":27268,"date":"2022-03-15T14:45:53","date_gmt":"2022-03-15T13:45:53","guid":{"rendered":"https:\/\/www.maiwald.eu\/publikationen\/epo-enlarged-board-to-consider-dosage-regimen-claims-managing-intellectual-property-2008-2\/"},"modified":"2022-12-27T13:43:17","modified_gmt":"2022-12-27T12:43:17","slug":"epo-enlarged-board-to-consider-dosage-regimen-claims-managing-intellectual-property-2008-2","status":"publish","type":"publikationen","link":"https:\/\/www.maiwald.eu\/cn\/publikationen\/epo-enlarged-board-to-consider-dosage-regimen-claims-managing-intellectual-property-2008-2\/","title":{"rendered":"EPO Enlarged Board to consider dosage regimen claims, Managing Intellectual Property, 2008"},"content":{"rendered":"","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-27268","publikationen","type-publikationen","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/cn\/wp-json\/wp\/v2\/publikationen\/27268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/cn\/wp-json\/wp\/v2\/publikationen"}],"about":[{"href":"https:\/\/www.maiwald.eu\/cn\/wp-json\/wp\/v2\/types\/publikationen"}],"version-history":[{"count":1,"href":"https:\/\/www.maiwald.eu\/cn\/wp-json\/wp\/v2\/publikationen\/27268\/revisions"}],"predecessor-version":[{"id":27269,"href":"https:\/\/www.maiwald.eu\/cn\/wp-json\/wp\/v2\/publikationen\/27268\/revisions\/27269"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/cn\/wp-json\/wp\/v2\/media?parent=27268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}